These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5560483)

  • 1. [Amelioration and normalization of the rapidity of dissolution by microcrystallization: application to methylprednisolone].
    Moran I; Gillard J; Roland M
    J Pharm Belg; 1971; 26(2):115-34. PubMed ID: 5560483
    [No Abstract]   [Full Text] [Related]  

  • 2. [Technological methods for improving the solubility and increasing the dissolution rate of slightly soluble drugs (author's transl)].
    Krowczynski L
    Pharmazie; 1982 Jan; 37(1):79-83. PubMed ID: 7071117
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs.
    Overhoff KA; Engstrom JD; Chen B; Scherzer BD; Milner TE; Johnston KP; Williams RO
    Eur J Pharm Biopharm; 2007 Jan; 65(1):57-67. PubMed ID: 16987642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The improved dissolution and prevention of ampoule breakage attained by the introduction of pretreatment into the production process of the lyophilized formulation of recombinant human Interleukin-11 (rhIL-11).
    Hirakura Y; Kojima S; Okada A; Yokohama S; Yokota S
    Int J Pharm; 2004 Nov; 286(1-2):53-67. PubMed ID: 15501002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of growth and dissolution of crystalline drugs].
    Tawashi R; Piccolo J
    Pharm Acta Helv; 1970 Nov; 45(11):653-77. PubMed ID: 4924221
    [No Abstract]   [Full Text] [Related]  

  • 6. Developing an environmentally benign process for the production of microparticles: amphiphilic crystallization.
    Murnane D; Marriott C; Martin GP
    Eur J Pharm Biopharm; 2008 May; 69(1):72-82. PubMed ID: 18082385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method.
    Li XS; Wang JX; Shen ZG; Zhang PY; Chen JF; Yun J
    Int J Pharm; 2007 Sep; 342(1-2):26-32. PubMed ID: 17566675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of lot-to-lot variations in the amorphous microstructure of lyophilized protein formulations.
    Hirakura Y; Yamaguchi H; Mizuno M; Miyanishi H; Ueda S; Kitamura S
    Int J Pharm; 2007 Aug; 340(1-2):34-41. PubMed ID: 17416473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low temperature properties of lyophilized solutions and their influence on lyophilization cycle design: pentamidine isethionate.
    Williams NA; Schwinke DL
    J Pharm Sci Technol; 1994; 48(3):135-9. PubMed ID: 8069514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lyophilization of pharmaceuticals: a literature review.
    Williams NA; Polli GP
    J Parenter Sci Technol; 1984; 38(2):48-59. PubMed ID: 6374086
    [No Abstract]   [Full Text] [Related]  

  • 13. Solubility of molecular crystals: polymorphism in the light of solubility theory.
    Bennema P; van Eupen J; van der Wolf BM; Los JH; Meekes H
    Int J Pharm; 2008 Mar; 351(1-2):74-91. PubMed ID: 17980982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an oral rutin nanocrystal formulation.
    Mauludin R; Müller RH; Keck CM
    Int J Pharm; 2009 Mar; 370(1-2):202-9. PubMed ID: 19114097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the aqueous dissolution of semicrystalline poly(ethylene oxide) using infrared chemical imaging: the effects of molecular weight and crystallinity.
    Coutts-Lendon C; Koenig JL
    Appl Spectrosc; 2005 Aug; 59(8):976-85. PubMed ID: 16105205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silica coatings on clarithromycin.
    Bele M; Dmitrasinovic D; Planinsek O; Salobir M; Srcic S; Gaberscek M; Jamnik J
    Int J Pharm; 2005 Mar; 291(1-2):149-53. PubMed ID: 15707741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of sequential injection analysis to pharmaceutical analysis.
    Pimenta AM; Montenegro MC; Araújo AN; Calatayud JM
    J Pharm Biomed Anal; 2006 Jan; 40(1):16-34. PubMed ID: 16326061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frosta: a new technology for making fast-melting tablets.
    Jeong SH; Fu Y; Park K
    Expert Opin Drug Deliv; 2005 Nov; 2(6):1107-16. PubMed ID: 16296813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infrared attenuated total reflectance (ATR) method for observing the water-mediated surface phase reversion of methylprednisolone II to I during dissolution.
    Higuchi WI; Hamlin WE; Mehta SC
    J Pharm Sci; 1969 Sep; 58(9):1145-6. PubMed ID: 5346083
    [No Abstract]   [Full Text] [Related]  

  • 20. [Physio-chemical and automatic methods of technological control in production of drugs. XI. Solubility and infrared spectra of p-nitro-alpha-acetylamino-acetophenone and p-nitro-alpha-acetylamino-beta oxypropiophenone].
    Portnov MA; Kaganskiĭ MM; Tetan'chuk KP; Chistiakov VE
    Med Prom SSSR; 1966 May; 20(5):46-50. PubMed ID: 5992738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.